Stocks
ZIOPHARM Oncology, Inc.ZIOP
NASDAQHealthcareBiotechnology$0.87-0.88%
A clinical-stage biotechnology company focused on developing gene and cell therapies for cancer, with research centered on engineered immune cells and controlled gene expression platforms. Its pipeline has historically targeted solid tumors and hematologic malignancies through early‑stage clinical p...
Market Cap: $208.1M52W Range: $0.76 – $5.95
Congressional Interest in ZIOPHARM Oncology, Inc. (ZIOP)
1 member of Congress has disclosed 1 trade in ZIOPHARM Oncology, Inc. (ZIOP), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading ZIOP?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-10-18 | Mark R Warner | sell | $250K – $500K |